Ranbaxy Takes Patent Arbitration Fight To Texas Justices

By Michelle Casady (April 26, 2018, 3:26 PM EDT) -- Ranbaxy Inc. has asked the Texas Supreme Court to intervene in a lawsuit where a lower appellate court allowed a fellow generic-drug maker to move forward in arbitration with claims it had been tricked into assigning patent rights to Ranbaxy, arguing the ruling is out of sync with federal arbitration law and common sense....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as